Adenosine receptors in the central nervous system. 1991

U Schwabe, and A Lorenzen, and S Grün
Department of Pharmacology, University of Heidelberg, Federal Republic of Germany.

Two major subclasses of adenosine receptors have been distinguished in the central nervous system, termed A1 and A2. They are coupled to G-proteins and regulate the activity of adenylyl cyclase, potassium channels and several other effector systems. Autoradiographic studies have shown that A1 receptors are mainly found in the hippocampus and the cerebellum, whereas A2 receptors are almost exclusively located in the striatum and olfactory tubercle. Furthermore, a novel adenosine binding protein was identified in bovine striatum by radioligand binding with [3H]5'-N-ethylcarboxamidoadenosine ([3H]NECA). The pharmacological profile of this NECA binding protein has been determined in competition experiments with adenosine receptor ligands. It can be distinguished from that of A2 adenosine receptors and other adenosine binding proteins such as S-adenosylhomocysteine hydrolase and the adenosine transporter.

UI MeSH Term Description Entries
D008959 Models, Neurological Theoretical representations that simulate the behavior or activity of the neurological system, processes or phenomena; includes the use of mathematical equations, computers, and other electronic equipment. Neurologic Models,Model, Neurological,Neurologic Model,Neurological Model,Neurological Models,Model, Neurologic,Models, Neurologic
D009928 Organ Specificity Characteristic restricted to a particular organ of the body, such as a cell type, metabolic response or expression of a particular protein or antigen. Tissue Specificity,Organ Specificities,Specificities, Organ,Specificities, Tissue,Specificity, Organ,Specificity, Tissue,Tissue Specificities
D011983 Receptors, Purinergic Cell surface proteins that bind PURINES with high affinity and trigger intracellular changes which influence the behavior of cells. The best characterized classes of purinergic receptors in mammals are the P1 receptors, which prefer ADENOSINE, and the P2 receptors, which prefer ATP or ADP. Methyladenine Receptors,Purine Receptors,Purinergic Receptor,Purinergic Receptors,Purinoceptors,Purine Receptor,Purinoceptor,Receptors, Methyladenine,Receptors, Purine,Receptor, Purine,Receptor, Purinergic
D001921 Brain The part of CENTRAL NERVOUS SYSTEM that is contained within the skull (CRANIUM). Arising from the NEURAL TUBE, the embryonic brain is comprised of three major parts including PROSENCEPHALON (the forebrain); MESENCEPHALON (the midbrain); and RHOMBENCEPHALON (the hindbrain). The developed brain consists of CEREBRUM; CEREBELLUM; and other structures in the BRAIN STEM. Encephalon
D000241 Adenosine A nucleoside that is composed of ADENINE and D-RIBOSE. Adenosine or adenosine derivatives play many important biological roles in addition to being components of DNA and RNA. Adenosine itself is a neurotransmitter. Adenocard,Adenoscan
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D019830 Adenosine-5'-(N-ethylcarboxamide) A stable adenosine A1 and A2 receptor agonist. Experimentally, it inhibits cAMP and cGMP phosphodiesterase activity. 5'-N-Ethylcarboxamidoadenosine,N-Ethylcarboxamidoadenosine,NECA,Adenosine-5'-N-ethyluronamide,N6-Ethyl-carboxamido Adenosine,5' N Ethylcarboxamidoadenosine,Adenosine 5' N ethyluronamide,Adenosine, N6-Ethyl-carboxamido,N Ethylcarboxamidoadenosine,N6 Ethyl carboxamido Adenosine

Related Publications

U Schwabe, and A Lorenzen, and S Grün
January 1984, Acta histochemica. Supplementband,
U Schwabe, and A Lorenzen, and S Grün
January 2009, Handbook of experimental pharmacology,
U Schwabe, and A Lorenzen, and S Grün
January 1983, Progress in neuro-psychopharmacology & biological psychiatry,
U Schwabe, and A Lorenzen, and S Grün
April 2000, Tanpakushitsu kakusan koso. Protein, nucleic acid, enzyme,
U Schwabe, and A Lorenzen, and S Grün
January 2019, Current pharmaceutical design,
U Schwabe, and A Lorenzen, and S Grün
March 1984, Brain research,
U Schwabe, and A Lorenzen, and S Grün
November 1998, The Journal of comparative neurology,
U Schwabe, and A Lorenzen, and S Grün
August 1984, Epilepsia,
U Schwabe, and A Lorenzen, and S Grün
January 1970, Journal of anatomy,
Copied contents to your clipboard!